Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kisha A. Mitchell"'
Autor:
James F Farrell, Loren Laine, Ronald R. Salem, Priya A. Jamidar, Thiruvengadam Muniraj, Kisha A. Mitchell, Harry R. Aslanian
Publikováno v:
World Journal of Gastroenterology
BACKGROUND Recurrent acute pancreatitis (RAP) may be a presenting feature of and an indication for resection of pancreatic cysts, including intra-ductal papillary mucinous neoplasm (IPMN). Few data are available regarding the prevalence of malignancy
Publikováno v:
Journal of Pathology Informatics, Vol 9, Iss 1, Pp 35-35 (2018)
Background: Autopsies usually serve to inform specific “causes of death” and associated mechanisms. However, multiple diseases can co-exist and interact leading to a final demise. We approached autopsy-produced data using network analysis in an u
Externí odkaz:
https://doaj.org/article/b3e283e3c5134402bf5a6a10c1c2447d
Autor:
David N. Assis, Thomas R. McCarty, Kisha A. Mitchell, Ananta Gurung, James L. Boyer, Dhanpat Jain
Publikováno v:
Human Pathology. 82:51-60
Summary We speculate that the “typical” histologic features (lymphoplasmacytic interface hepatitis, emperipolesis, and hepatocyte rosettes) of autoimmune hepatitis (AIH) are related to severity of hepatitis rather than etiology. We critically app
Autor:
Colleen N. Feriod, Mateus T. Guerra, André G. Oliveira, Xiaoyong Yang, Kisha A. Mitchell – Richards, Joao Paulo Camporez, Barbara E. Ehrlich, Anton M. Bennett, Michael J. Jurczak, Michael H. Nathanson, Gerald I. Shulman, Hai Bin Ruan, Lily Nguyen
Publikováno v:
Hepatology Communications
Fatty liver is the most common type of liver disease, affecting nearly one third of the U.S. population and more than half a billion people worldwide. Abnormalities in endoplasmic reticulum (ER) calcium handling and mitochondrial function each have b
Autor:
Lawrence H. Staib, Jay Pahade, David Juice, Gary M. Israel, Kisha A. Mitchell, Dan Cornfeld, Jeffrey C. Weinreb
Publikováno v:
Abdominal Radiology. 41:1270-1284
To determine added value of hepatobiliary phase (HBP) using gadoxetate disodium compared to MRI with extracellular gadolinium-based contrast agent (GBCA) for detection of primary hepatic malignancies in a single imaging session. IRB approved this HIP
Publikováno v:
Diagnostic Cytopathology. 44:147-151
Clear cell hepatocellular carcinoma (CCHCC) is an uncommon morphologic variant of HCC and rarely invades into the main bile ducts. Here we describe a case of CCHCC that was diagnosed by bile duct brushing cytology. Liquid-based preparation of brushin
Publikováno v:
ACG Case Reports Journal
Sofosbuvir and simeprevir are used for the treatment of chronic hepatitis C (HCV) genotype 1. Both drugs have been well-tolerated, with diarrhea noted in 6% cases with sofosbuvir, 16% with sofosbuvir plus simeprevir, and 0% with simeprevir. No prior
Autor:
Jon M. Davison, Maria Westerhoff, Kenneth P. Batts, Alyssa M. Krasinskas, Rebecca Wilcox, Joanna Gibson, Joseph Rank, Oscar W. Cummings, Scott Ketover, Sanjay Kakar, Kisha A. Mitchell, Anthony Mattia, Bita V. Naini, Rhonda K. Yantiss, Sarah M. Dry
Publikováno v:
American Journal of Surgical Pathology. 37:e12-e22
Helicobacter pylori is a major cause of gastroduodenal injury, gastric cancer, and lymphoma, and, thus, there is great interest in its detection and eradication. Several detection methods are available, including histochemical and immunohistochemical
Publikováno v:
Journal of Clinical Gastroenterology. 47:781-785
Recently, a monoclonal antibody to cytotoxic T-lymphocyte–associated antigen 4, ipilimumab, was approved for the treatment of metastatic melanoma. One of the most common side effects associated with this therapy is diarrhea and colitis. We report 3
Autor:
Marie E. Robert, Pei Hui, Armagan Gunal, Barton Kenney, Ruliang Xu, Selim Kilic, Dhanpat Jain, Kisha A. Mitchell
Publikováno v:
Journal of Clinical Gastroenterology. 47:509-514
Background Mutations in the KRAS gene occur at an early stage in the development of colorectal carcinoma. Importantly, KRAS mutation predicts resistance to anti-epidermal growth factor receptor therapy in stage IV disease. Goals The aim of the curren